The Journal of General Physiology
VISIT JCB ONLINE!
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 14 February 2000. doi:10.1085/jgp.115.3.229
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JGP
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitcheson, J. S.
Right arrow Articles by Sanguinetti, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitcheson, J. S.
Right arrow Articles by Sanguinetti, M. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1295/2000/3/229/ $5.00
The Journal of General Phyiology, Volume 115, Number 3, March 1, 2000 229-240


Original Article

Trapping of a Methanesulfonanilide by Closure of the HERG Potassium Channel Activation Gate

John S. Mitchesona, Jun Chena, and Michael C. Sanguinettia
a From the Department of Medicine, Division of Cardiology, Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah 84112

Correspondence to: John S. Mitcheson, Eccles Institute of Human Genetics, University of Utah, 15 North 2030 East, Rm. 4220, Salt Lake City, UT 84112. Fax:801-585-3501 E-mail:john.mitcheson{at}hci.utah.edu.

Released online: 14 February 2000

Deactivation of voltage-gated potassium (K+) channels can slow or prevent the recovery from block by charged organic compounds, a phenomenon attributed to trapping of the compound within the inner vestibule by closure of the activation gate. Unbinding and exit from the channel vestibule of a positively charged organic compound should be favored by membrane hyperpolarization if not impeded by the closed gate. MK-499, a methanesulfonanilide compound, is a potent blocker (IC50 = 32 nM) of HERG K+ channels. This bulky compound (7 x 20 Å) is positively charged at physiological pH. Recovery from block of HERG channels by MK-499 and other methanesulfonanilides is extremely slow (Carmeliet 1992 Down; Ficker et al. 1998 Down), suggesting a trapping mechanism. We used a mutant HERG (D540K) channel expressed in Xenopus oocytes to test the trapping hypothesis. D540K HERG has the unusual property of opening in response to hyperpolarization, in addition to relatively normal gating and channel opening in response to depolarization (Sanguinetti and Xu 1999 Down). The hyperpolarization-activated state of HERG was characterized by long bursts of single channel reopening. Channel reopening allowed recovery from block by 2 µM MK-499 to occur with time constants of 10.5 and 52.7 s at -160 mV. In contrast, wild-type HERG channels opened only briefly after membrane hyperpolarization, and thus did not permit recovery from block by MK-499. These findings provide direct evidence that the mechanism of slow recovery from HERG channel block by methanesulfonanilides is due to trapping of the compound in the inner vestibule by closure of the activation gate. The ability of HERG channels to trap MK-499, despite its large size, suggests that the vestibule of this channel is larger than the well studied Shaker K+ channel.

Key Words: MK-499, voltage clamp, Xenopus oocyte


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JGPHome page
S. L. Wynia-Smith, A. L. Gillian-Daniel, K. A. Satyshur, and G. A. Robertson
hERG Gating Microdomains Defined by S6 Mutagenesis and Molecular Modeling
J. Gen. Physiol., October 27, 2008; 132(5): 507 - 520.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Sale, J. Wang, T. J. O'Hara, D. J. Tester, P. Phartiyal, J.-Q. He, Y. Rudy, M. J. Ackerman, and G. A. Robertson
Physiological Properties of hERG 1a/1b Heteromeric Currents and a hERG 1b-Specific Mutation Associated With Long-QT Syndrome
Circ. Res., September 26, 2008; 103(7): e81 - e95.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
M. A. Pineros, G. M.A. Cancado, and L. V. Kochian
Novel Properties of the Wheat Aluminum Tolerance Organic Acid Transporter (TaALMT1) Revealed by Electrophysiological Characterization in Xenopus Oocytes: Functional and Structural Implications
Plant Physiology, August 1, 2008; 147(4): 2131 - 2146.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. C. Hancox and A. F. James
Refining Insights into High-Affinity Drug Binding to the Human Ether-a-go-go-Related Gene Potassium Channel
Mol. Pharmacol., June 1, 2008; 73(6): 1592 - 1595.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Hardman, P. J. Stansfeld, S. Dalibalta, M. J. Sutcliffe, and J. S. Mitcheson
Activation Gating of hERG Potassium Channels: S6 GLYCINES ARE NOT REQUIRED AS GATING HINGES
J. Biol. Chem., November 2, 2007; 282(44): 31972 - 31981.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nakajima, K. Hayashi, P. C. Viswanathan, M.-Y. Kim, M. Anghelescu, K. A. Barksdale, W. Shuai, J. R. Balser, and S. Kupershmidt
HERG Is Protected from Pharmacological Block by {alpha}-1,2-Glucosyltransferase Function
J. Biol. Chem., February 23, 2007; 282(8): 5506 - 5513.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. A. Hoekenga, L. G. Maron, M. A. Pineros, G. M. A. Cancado, J. Shaff, Y. Kobayashi, P. R. Ryan, B. Dong, E. Delhaize, T. Sasaki, et al.
From the Cover: AtALMT1, which encodes a malate transporter, is identified as one of several genes critical for aluminum tolerance in Arabidopsis
PNAS, June 20, 2006; 103(25): 9738 - 9743.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Kamiya, R. Niwa, J. S. Mitcheson, and M. C. Sanguinetti
Molecular Determinants of hERG Channel Block
Mol. Pharmacol., May 1, 2006; 69(5): 1709 - 1716.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Cockerill and J. S. Mitcheson
Direct Block of Human Ether-a-go-go-Related Gene Potassium Channels by Caffeine
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 860 - 868.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Perry, P. J. Stansfeld, J. Leaney, C. Wood, M. J. de Groot, D. Leishman, M. J. Sutcliffe, and J. S. Mitcheson
Drug Binding Interactions in the Inner Cavity of hERG Channels: Molecular Insights from Structure-Activity Relationships of Clofilium and Ibutilide Analogs
Mol. Pharmacol., February 1, 2006; 69(2): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Lin, J. Guo, H. Gang, P. Wojciechowski, J. T. Wigle, and S. Zhang
Intracellular K+ Is Required for the Inactivation-Induced High-Affinity Binding of Cisapride to HERG Channels
Mol. Pharmacol., September 1, 2005; 68(3): 855 - 865.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
C. E. Clancy and R. S. Kass
Inherited and Acquired Vulnerability to Ventricular Arrhythmias: Cardiac Na+ and K+ Channels
Physiol Rev, January 1, 2005; 85(1): 33 - 47.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Thomas, B. C. Hammerling, A.-B. Wimmer, K. Wu, E. Ficker, Y. A. Kuryshev, D. Scherer, J. Kiehn, H. A. Katus, W. Schoels, et al.
Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X)
Cardiovasc Res, December 1, 2004; 64(3): 467 - 476.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. J. Witchel, C. E. Dempsey, R. B. Sessions, M. Perry, J. T. Milnes, J. C. Hancox, and J. S. Mitcheson
The Low-Potency, Voltage-Dependent HERG Blocker Propafenone--Molecular Determinants and Drug Trapping
Mol. Pharmacol., November 1, 2004; 66(5): 1201 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-S. Bian, A. Kagan, and T. V. McDonald
Molecular analysis of PIP2 regulation of HERG and IKr
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2154 - H2163.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo
Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole
J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Perry, M. J. de Groot, R. Helliwell, D. Leishman, M. Tristani-Firouzi, M. C. Sanguinetti, and J. Mitcheson
Structural Determinants of HERG Channel Block by Clofilium and Ibutilide
Mol. Pharmacol., August 1, 2004; 66(2): 240 - 249.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. M. Mullins, S. Z. Stepanovic, N. B. Gillani, A. L. George Jr, and J. R. Balser
Functional interaction between extracellular sodium, potassium and inactivation gating in HERG channels
J. Physiol., August 1, 2004; 558(3): 729 - 744.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Westenskow, I. Splawski, K. W. Timothy, M. T. Keating, and M. C. Sanguinetti
Compound Mutations: A Common Cause of Severe Long-QT Syndrome
Circulation, April 20, 2004; 109(15): 1834 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon
Pharmacology of cardiac potassium channels
Cardiovasc Res, April 1, 2004; 62(1): 9 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Fernandez, A. Ghanta, G. W. Kauffman, and M. C. Sanguinetti
Physicochemical Features of the hERG Channel Drug Binding Site
J. Biol. Chem., March 12, 2004; 279(11): 10120 - 10127.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Brugada, K. Hong, R. Dumaine, J. Cordeiro, F. Gaita, M. Borggrefe, T. M. Menendez, J. Brugada, G. D. Pollevick, C. Wolpert, et al.
Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG
Circulation, January 6, 2004; 109(1): 30 - 35.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Seebohm, J. Chen, N. Strutz, C. Culberson, C. Lerche, and M. C. Sanguinetti
Molecular Determinants of KCNQ1 Channel Block by a Benzodiazepine
Mol. Pharmacol., July 1, 2003; 64(1): 70 - 77.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
M. Zhang, Y. V. Korolkova, J. Liu, M. Jiang, E. V. Grishin, and G.-N. Tseng
BeKm-1 Is a HERG-Specific Toxin that Shares the Structure with ChTx but the Mechanism of Action with ErgTx1
Biophys. J., May 1, 2003; 84(5): 3022 - 3036.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Ishii, M. Nagai, M. Takahashi, and M. Endoh
Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency
Cardiovasc Res, March 1, 2003; 57(3): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Wang, K. Della Penna, H. Wang, J. Karczewski, T. M. Connolly, K. S. Koblan, P. B. Bennett, and J. J. Salata
Functional and pharmacological properties of canine ERG potassium channels
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H256 - H267.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
J. Liu, M. Zhang, M. Jiang, and G.-N. Tseng
Structural and Functional Role of the Extracellular S5-P Linker in the HERG Potassium Channel
J. Gen. Physiol., October 29, 2002; 120(5): 723 - 737.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
H. P. Larsson
The Search Is on for the Voltage Sensor-to-gate Coupling
J. Gen. Physiol., September 30, 2002; 120(4): 475 - 481.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Chen, G. Seebohm, and M. C. Sanguinetti
Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels
PNAS, September 17, 2002; 99(19): 12461 - 12466.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Mbai, S. Rajamani, and C. T January
The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels
Cardiovasc Res, September 1, 2002; 55(4): 799 - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. A. Volberg, B. J. Koci, W. Su, J. Lin, and J. Zhou
Blockade of Human Cardiac Potassium Channel Human Ether-a-go-go-Related Gene (HERG) by Macrolide Antibiotics
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 320 - 327.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Tristani-Firouzi, J. Chen, and M. C. Sanguinetti
Interactions between S4-S5 Linker and S6 Transmembrane Domain Modulate Gating of HERG K+ Channels
J. Biol. Chem., May 17, 2002; 277(21): 18994 - 19000.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Thomas, B. Gut, G. Wendt-Nordahl, and J. Kiehn
The Antidepressant Drug Fluoxetine Is an Inhibitor of Human Ether-A-Go-Go-Related Gene (HERG) Potassium Channels
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Ficker, W. Jarolimek, and A. M. Brown
Molecular Determinants of Inactivation and Dofetilide Block in ether a-go-go (EAG) Channels and EAG-Related K+ Channels
Mol. Pharmacol., December 1, 2001; 60(6): 1343 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Kamiya, J. S. Mitcheson, K. Yasui, I. Kodama, and M. C. Sanguinetti
Open Channel Block of HERG K+ Channels by Vesnarinone
Mol. Pharmacol., August 1, 2001; 60(2): 244 - 253.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Zhang, S. Rajamani, Y. Chen, Q. Gong, Y. Rong, Z. Zhou, A. Ruoho, and C. T. January
Cocaine Blocks HERG, but Not KvLQT1+minK, Potassium Channels
Mol. Pharmacol., April 16, 2001; 59(5): 1069 - 1076.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Thomas, G. Wendt-Nordahl, K. Röckl, E. Ficker, A. M. Brown, and J. Kiehn
High-Affinity Blockade of Human Ether-A-Go-Go-Related Gene Human Cardiac Potassium Channels by the Novel Antiarrhythmic Drug BRL-32872
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 753 - 761.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. E. O'Leary
Inhibition of Human Ether-A-Go-Go Potassium Channels by Cocaine
Mol. Pharmacol., February 1, 2001; 59(2): 269 - 277.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. Numaguchi, F. M. Mullins, J. P. Johnson Jr., D. C. Johns, S. S. Po, I. C.-H. Yang, G. F. Tomaselli, and J. R. Balser
Probing the Interaction Between Inactivation Gating and Dd-Sotalol Block of HERG
Circ. Res., November 24, 2000; 87(11): 1012 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. S. Kass and C. Cabo
Channel structure and drug-induced cardiac arrhythmias
PNAS, October 24, 2000; 97(22): 11683 - 11684.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Mitcheson, J. Chen, M. Lin, C. Culberson, and M. C. Sanguinetti
A structural basis for drug-induced long QT syndrome
PNAS, September 22, 2000; (2000) 210244497.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Chen, J. S. Mitcheson, M. Lin, and M. C. Sanguinetti
Functional Roles of Charged Residues in the Putative Voltage Sensor of the HCN2 Pacemaker Channel
J. Biol. Chem., November 10, 2000; 275(46): 36465 - 36471.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Mitcheson, J. Chen, M. Lin, C. Culberson, and M. C. Sanguinetti
A structural basis for drug-induced long QT syndrome
PNAS, October 24, 2000; 97(22): 12329 - 12333.
[Abstract] [Full Text] [PDF]



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents